Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019033051) RNA APTAMERS AGAINST TRANSFERRIN RECEPTOR (TFR)
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2019/033051 International Application No.: PCT/US2018/046343
Publication Date: 14.02.2019 International Filing Date: 10.08.2018
IPC:
A61K 31/7105 (2006.01) ,A61K 31/713 (2006.01) ,A61K 45/06 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7088
Compounds having three or more nucleosides or nucleotides
7105
Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7088
Compounds having three or more nucleosides or nucleotides
713
Double-stranded nucleic acids or oligonucleotides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applicants:
CITY OF HOPE [US/US]; 1500 E. Duarte Road Duarte, CA 91010-3000, US
APTERNA LIMITED [GB/GB]; 1 Vincent Square London SW1P 2PN, GB
Inventors:
ROSSI, John, J.; US
YOON, Sorah; US
HABIB, Nagy; GB
Agent:
BOLCOME III, Robert, E.; US
AZRIN, Linda, B.; US
ADAMS, Lisa; US
AMENDT, Kevin, C.; US
BAUER, John, A.; US
Priority Data:
62/544,22011.08.2017US
62/671,60415.05.2018US
Title (EN) RNA APTAMERS AGAINST TRANSFERRIN RECEPTOR (TFR)
(FR) APTAMÈRES D’ARN CONTRE LE RÉCEPTEUR DE TRANSFERRINE (TFR)
Abstract:
(EN) A ribonucleic acid compound is disclosed, the ribonucleic acid compound comprising, or consisting of, an RNA sequence having at least 90% sequence identity to SEQ ID NO: 1, wherein said RNA sequence has a length of 29 nucleotides or fewer, and wherein the RNA sequence is capable of binding to a transferrin receptor (TfR).
(FR) La présente invention concerne un composé d’acide ribonucléique, le composé d’acide ribonucléique comprenant, ou étant constitué de, une séquence d’ARN ayant au moins 90 % d’identité de séquence avec SEQ ID NO: 1, ladite séquence d’ARN ayant une longueur de 29 nucléotides ou moins, et la séquence d’ARN pouvant se lier à un récepteur de transferrine (TfR).
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)